Drugs Online

LERKA Zanidip

Drugs Online » Prescription Drugs 10 » LERKA Zanidip

Lercanidipine Hydrochloride belongs to a group of medicines called calcium channel blockers which act on the heart and blood vessels. Lercanidipine slows the movement of calcium through cells which has two results. It decreases the rate at which the heart beats and also has a widening effect on blood vessels. This combination causes blood pressure to be reduced. What is it used for?High blood pressure (hypertension)

Buy LERKA Zanidip and other Prescription Drugs 10 products online at Medstore.

Buy Online at Medstore - Click Here!

About LERKA Zanidip:

Product Type: Prescription Drugs 10

LERKA ( Zanidip Generic Lercanidipine )

LERKA (Zanidip Generic Lercanidipine)

Zanidip Generic Lercanidipine

10 mg Tab Zanidip Generic Lercanidipine LERKA

View more Prescription Drugs 10

Previous Product  Next Product

Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.